Schedule 13G ownership disclosure

HORIZON PHARMA, INC.

Security class unavailable · CUSIP: 44047T109

Event date: 2014-08-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.7800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950159-14-000392
Form type
SC 13G/A
Filer
Horizon Therapeutics Public Ltd Co
CIK
CIK 1492426
Filed
Aug 07, 2014
Reporting period
Aug 05, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub